CSAGE, or Capture Selective Amplify and Gate, is a cutting-edge molecular biology technique designed to selectively target and analyze specific RNA transcripts from a complex mixture of RNA molecules. This method is particularly useful in transcriptomics, where it aids in the study of gene expression and regulation.The CSAGE technique involves several key steps. First, it uses molecular "capture" probes that are designed to specifically bind to the RNA transcripts of interest. These probes are typically short, complementary DNA or RNA sequences tailored to match the target RNA. Once bound, these probes allow for the selective isolation of the desired RNA from a complex sample, such as a cell or tissue extract.
Following capture, the targeted RNA undergoes an amplification process. This step is crucial because it increases the quantity of the RNA of interest, making it more detectable and analyzable. Amplification is typically achieved through techniques like PCR (Polymerase Chain Reaction), which can efficiently replicate specific RNA sequences.The final step, "gate," refers to the analysis and quantification of the amplified RNA. This can be done through various methods, such as sequencing or hybridization-based approaches. The data obtained provide insights into the abundance and variants of the targeted RNA transcripts, offering valuable information about gene expression patterns and regulation mechanisms. CSAGE is particularly advantageous in scenarios where precise and selective analysis of specific RNA molecules is required. It is used in research areas like cancer biology, developmental biology, and neuroscience, helping scientists understand complex gene expression dynamics in health and disease.
VER TAMBIÉN ....
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
La 5-azacitidina, un inhibidor de la metiltransferasa del ADN, puede reactivar genes silenciados en células cancerosas, afectando potencialmente a la expresión o actividad de la CSAGE. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Un inhibidor de la histona desacetilasa, la tricostatina A, modifica la estructura de la cromatina y puede influir indirectamente en la expresión de la CSAGE. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Al igual que la tricostatina A, el vorinostat es un inhibidor de la histona deacetilasa que podría afectar indirectamente a la CSAGE al alterar la expresión génica. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
El cisplatino, un fármaco quimioterapéutico, induce daños en el ADN, lo que podría influir indirectamente en la expresión o actividad de la CSAGE en las células cancerosas. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
La doxorrubicina, un antibiótico antraciclínico utilizado en la quimioterapia contra el cáncer, podría afectar a las células que expresan CSAGE induciendo daños en el ADN y apoptosis. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
La rapamicina, un inhibidor de mTOR, puede modular el crecimiento y la proliferación celular, afectando potencialmente a la función CSAGE en las células cancerosas. | ||||||